Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: J Neurochem. 2020 Mar 13;156(5):589–603. doi: 10.1111/jnc.14990

Reelin signaling modulates GABAB receptor function in the neocortex

Mohammad IK Hamad 1,2, Abdalrahim Jbara 1, Obada Rabaya 1, Petya Petrova 1, Solieman Daoud 1, Nesrine Melliti 1, Maurice Meseke 1, David Lutz 1, Elisabeth Petrasch-Parwez 1, Jan Claudius Schwitalla 3, Melanie D Mark 3, Stefan Herlitze 4, Gebhard Reiss 2, Joachim Herz 5, Eckart Förster 1
PMCID: PMC7442713  NIHMSID: NIHMS1573406  PMID: 32083308

Abstract

Reelin is a protein that is best known for its role in controlling neuronal layer formation in the developing cortex. Here, we studied its role for postnatal cortical network function, which is poorly explored. To preclude early cortical migration defects caused by Reelin deficiency, we used a conditional Reelin knock-out (RelncKO) mouse, and induced Reelin deficiency postnatally. Induced Reelin deficiency caused hyperexcitability of the neocortical network in vitro and ex-vivo. Blocking Reelin binding to its receptors ApoER2 and VLDLR resulted in a similar effect. Hyperexcitability in RelncKO organotypic slice cultures (OTCs) could be rescued by co-culture with wildtype OTCs. Moreover, the GABAB receptor (GABABR) agonist baclofen failed to activate and the antagonist CGP35348 failed to block GABABRs in RelncKO mice. Immunolabelling of RelncKO cortical slices revealed a reduction in GABABR1 and GABABR2 surface expression at the plasma membrane and western blot of RelncKO cortical tissue revealed decreased phosphorylation of the GABABR2 subunit at serine 892 and increased phosphorylation at serine 783, reflecting receptor deactivation and proteolysis. These data show a role of Reelin in controlling early network activity, by modulating GABABR function.

Graphical Abstract

graphic file with name nihms-1573406-f0001.jpg

We suggested the following modification of synaptic function after conditional reelin knockout in the cerebral cortex: After Reelin deficiency, the presynaptic reelin signaling cascade via the reelin receptors ApoER2 and Vldlr and the adaptor protein Dab1, is no longer activated. This causes a decreased phosphorylation of presynaptic GABAB-receptors at S892, while phosphorylation at S783 increases, likely induced by AMP-activated protein kinase (AMPK). As a consequence, GABAB-receptors are degraded, calcium influx via NMDA-receptors and synaptic vesicle release is increased. We believe that our findings revealed a new synaptic function of reelin expressed by cortical interneurons during cortical development.

Introduction

Reelin is an extracellular glycoprotein that controls several aspects of mammalian brain development and function. The most prominent role of Reelin is the control of neuronal migration and layer formation in the developing cerebral cortex, as evidenced by numerous histological studies on reeler mutant mice that lack Reelin expression due to a defect of the Reelin gene (Caviness 1976; Curran and D'Arcangelo 1998; Lambert de Rouvroit and Goffinet 1998). Through signaling via its membrane receptors (Bock and May 2016; Cooper and Howell 1999), Reelin guides the migration of newborn neurons and orchestrates the development of cortical layers. In the developing and adult brain, the majority of GABAergic interneurons in the neocortex expresses Reelin. The canonical Reelin signaling cascade involves direct binding of Reelin to ApoER2 and VLDLR and subsequent activation of the intracellular adapter protein Disabled-1 (DAB1) by tyrosine phosphorylation (Cooper and Howell 1999; D'Arcangelo et al. 1999; Hiesberger et al. 1999; Howell et al. 2000; Trommsdorff et al. 1999).

In the absence of Reelin or its receptors, the process of neuronal migration is compromised, which causes severe abnormalities in cortical lamination. The resulting phenotype was initially described as an inversion of the layers (Caviness 1982; Caviness and Sidman 1973). Although it had already been shown that deviant barrel formation in the somatosensory cortex of the reeler is compromised (Caviness 1976; Welt and Steindler 1977), it has been recently demonstrated that the barrel field retains its proper somatotopic organization (Guy et al. 2015; Wagener et al. 2010). Besides its cortical migration defects, the reeler mutants exhibit cerebellar hypoplasia and a neurological phenotype that is characterized by ataxia ( (Miyata et al. 1997). A similar phenotype was observed in human patients carrying homozygous mutations in the Reelin gene, resulting in lissencephaly and cerebellar hypoplasia (Hong et al. 2000). Moreover, in humans, heterozygous Reelin mutations were described that cause autosomal-dominant temporal lobe epilepsy (Dazzo et al. 2015).

Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the mammalian CNS and plays a key role in modulating neuronal activity. GABA mediates its action via two different classes of receptors, ionotropic receptors (GABAA, GABAC) and metabotropic GABAB receptors. The GABAB receptors are guanine nucleotide-binding protein (G protein)-coupled metabotropic receptors that modulate Ca2+- and potassium (K+) – channels, and elicit both presynaptic and slow postsynaptic inhibition (Benarroch 2012; Bettler et al. 2004). In particular, presynaptic GABABRs are coupled to Ca2+ channels, regulating the release of neurotransmitters, while postsynaptic GABABRs are coupled to K+ inward rectifying (Kir) channels (Kir3), regulating postsynaptic slow inhibition (Pinard et al. 2010). Remarkably, GABA does not mediate hyperpolarization-dependent inhibition during early development, since GABAAR signaling is mainly depolarizing and excitatory during this period, while GABABRs are uncoupled from G-proteins and Kir3 channels until the end of the first postnatal week (Ben-Ari et al. 2012; Fukuda et al. 1993; Owens and Kriegstein 2002). Moreover, GABA is abundant in the neonatal nervous system and activates GABABRs (Ben-Ari et al. 2007). In the cortex, GABABR1 and GABABR2 were detected by immunocytochemistry as early as E14, and GABAB1Rs were found to colocalize with GABAB2Rs in neurons of the marginal zone and the subplate, indicating that these proteins are coexpressed and could be forming functional GABABRs during prenatal development in vivo (López-Bendito et al. 2002). In the murine neocortex, Reelin-haploinsufficiency has been shown to disrupt the developmental trajectory of GABA excitation/inhibition balance (Bouamrane et al. 2016), suggesting a possible interaction between Reelin and the GABA receptors.

Adult conditionally induced RelncKO mice exhibited altered hippocampal LTP and a subtle behavioural phenotype while the cortical architecture was shown to be indistinguishable from their wild-type littermate (Lane-Donovan et al. 2015). The question whether Reelin deficiency affects early cortical neuronal activity remains to be solved. To address this question, we investigated the effect of postnatally induced Reelin deficiency on Ca2+ signaling and on synaptic function in the neocortex of RelncKO mice. Since synaptic release is mainly controlled by GABABRs that mediate inhibitory GABA effects around the second postnatal week, we focused here on a potential interaction between Reelin signaling and GABABRs function.

Material and Methods

Reelin conditional knockout mice (RelncKO)

Animals were housed in a standard 12-h light cycle and fed ad libitum with standard mouse chow. All care and use of experimental animals were respected according to the Federal German law with permission Nr. 84-02.04.2016.A383 and the ARRIVE guidelines. The generation of the conditional RelncKO line was previously described (Lane-Donovan et al. 2015). To obtain conditional Reelin knockout mice (Relnflox/flox CAG-CreERT2 mice), we crossed Relnflox/flox mice with hemizygous tamoxifen-inducible Cre recombinase expressing mice (CAG-CreERT2) (Hayashi and McMahon 2002). For the experiments, only Relnflox/flox CAG-CreERT2 male mice were selected and then crossed with Relnflox/flox female mice to generate Relnflox/flox wildtype (WT) and Relnflox/flox CAG-CreERT2 (RelncKO) siblings as verified by PCR. The cKO mouse line ubiquitously expresses a fusion protein comprising Cre recombinase and a mutated form of the estrogen receptor (Cre-ERT2). Tamoxifen administration induces nuclear Cre activation and knockout of the floxed Reelin gene. 20 μl tamoxifen (Cat# T5648, Sigma, Deisenhofen, Germany) was dissolved in corn oil at a concentration of 20 mg/ml by shaking overnight at 37°C and fed to newly born pups at P1 for 5 consecutive days. At P14 animals were deep anesthetized with isoflurane CP® (CP-Pharma, Burgdorf, Germany) to minimize suffering and killed by decapitation. Ex-vivo slices from somatosensory cortex were explanted from each animal for acute slice preparation at P14 or at P0 for OTCs preparation by respecting the coordinates indicated in Allens mouse brain atlas. A graphical flow chart for ex-vivo experimental procedures is shown in (Fig. 1A). For each outcome measure, we used 5 Relnwt and 5 RelncKO mice (each experiment was repeated 3 times). In total 390 animals were used for this study. From each animal we obtained 3-4 slices. We recorded from each slice 3 different areas of interests (ROI). In each area of interest, we averaged amplitude, frequency and Ca2+ transient half-width of 6 cells. The average of the 3 ROI has been plotted in the box-plot as single value. This study was not pre-registered. No exclusion criteria were pre-determined and the study was exploratory. No blinding, randomization was performed to allocate subjects in the study. No sample size calculation was performed in this study.

Fig. 1. Recording of neuronal activity in RelncKO mice.

Fig. 1.

(A) Graphical flow chart of experimental procedures. In each experiment, slices were prepared from 5 wt and 5 RelncKO mice. (B): Confocal image examples of OGB-1 AM loaded P14 acute neocortical wt and RelncKO slices. Scale bars: 20 μm. (C): Typical example of spike waveform from a recorded cell which shows amplitude and Ca+2 transient (spike) half-width. (D): The box-plot in the graph represents the values of maximal increase in Ca2+-signal amplitude in control wt and RelncKO acute slices expressed as ΔF/F0, which is unaltered. (E): The Ca2+ frequency is significantly higher in the RelncKO when compared to wt, and (F) the Ca+2 transient half-width is significantly higher in RelncKO when compared to wt. Mann–Whitney U test; ***P<0.001. The number of acute slices analysed is indicated above the box-plots in (D). To assess pyramidal cells and interneurons separately, acute slices were transfected with GCaMP6s plasmid to visualize the cell type (G-J). (G): Confocal images of a GCaMP6s transfected pyramidal cell in a wt P14 acute neocortical slice during Ca2+-imaging at resting fluorescence (F0) and at maximal amplitude peak. Scale bars: 20 μm. (H): The box-plot in the graph shows no change in maximal Ca2+-amplitude signals between control wt and RelncKO groups for both cell types, but shows (I and J) a significant increase in Ca2+ frequency and Ca+2 transients half-width in RelncKO recorded slices in comparison to wt for both pyramidal cells and interneurons. One-way ANOVA on Ranks followed by Dunn’s Multiple Comparison Test, ***p < 0.001 and **P<0.01. The number of single cells in (H-J) is indicated above the box-plots in (H). The data is obtained from 3 independent acute slice preparations.

PCR and genotyping

All samples were stored at −20°C until PCR analysis. DNA from samples of ear, tail and brain tissue were isolated with ReliaPrep gDNA kit (Cat# A205, Promega, Mannheim, Germany). All procedures were performed according to protocols provided by the manufacturer. The amounts of DNA isolated from the various samples were determined by spectrophotometry with the Genova Nano system (Jenway). DNA was amplified by PCR. PCR reactions were performed in a total volume of 50 μl reaction mixture containing 200 ng of template DNA, Soriano buffer (0.67 M Tris, 0.16 M ammonium sulphate, 67 mM MgCl2, 67 μM EDTA and 50 mM β-Mercaptoethanol), Taq polymerase, 2 μL DMSO and 10 mM dNTPs. For genotyping we used the following primers: Wildtype mice, forward primer 5′-ATAAACTGGTGCTTATGTGACAGG-3′, reverse primer 5′-AGACAATGCTAACAACAGCAAGC-3′ (450 bp). Relnflox/flox mice, forward primer 5′-GCTCTGGCCAAGCTTTATC-3′, reverse primer 5′- CGCGATCGATAACTTCGTATAGCATAC-3′ (1200 bp). For detection of CAG-CreERT2, forward primer 5′-ATTGCTGTCACTTGGTCGTGG-3′, reverse primer 5′-GGAAAATGCTTCTGTCCGTTTGC-3′ (200 bp). The amplification products were verified on a 2% agarose gel in TBE buffer.

Organotypic cultures and pharmacological treatment

OTCs were prepared from newborn postnatal day 0 (P0) mice. 3-4 OTCs from somatosensory cortex were collected from each animal. All solutions used for OTCs preparation were sterile and all preparations were performed in a laminar air flow bench with horizontal counter flow (Horizontal Flow, ICN, Biomedicals, Eschwege; Germany). The mice were briefly anesthetized and decapitated. The skull was removed gently, and the cortex was placed on the chopper plate (McIllwain, Bad Schwalbach, Germany). Somatosensory cortex was cut into 350 μm thick slices, and the slices were gently transferred into ice cold buffered salt solution (GBSS, Cat# 24020117, Gibco, Eggenstein, Germany) containing 25 mM D-glucose. After 30 minutes of recovery, the slices were transferred onto coverslips (12 x 24 mm, Kindler). A mixture of chicken plasma (Sigma) and GBBS/thrombin (Merck) was mixed in a proportion of 2:1 and then allowed to coagulate for 45 min. The coverslip was transferred into a roller tube (Nunc) filled with 750 μl semiartificial medium and placed in a roller incubator at 37 °C. To induce the knockout, the OTCs were directly stimulated after preparation with 1 μM (Z)-4-hydroxytamoxifen (4-OHT) (Cat# 3412, Tocris, Wiesbaden, Germany) for 5 consecutive days and kept for experiments until DIV14. A graphical flow chart for OTCs experimental procedures is shown in (Fig. 2A). For the Ca2+ imaging experiments, the following drugs were used: Baclofen (10 μM, Cat# 0417, Tocris, Wiesbaden, Germany), CGP35348 (10 μM, Cat# 1245/10, Tocris, Wiesbaden, Germany), PP2 (1 μM, Cat# 1407/10, Tocris, Wiesbaden, Germany), pertussis toxin (PTX, 500 ng/mL, Cat# 3097/50U, Tocris, Wiesbaden, Germany), CNQX (10 μM, Cat# 0190/10, Tocris, Wiesbaden, Germany) and APV (50 μM, Cat# 0190/10, Tocris, Wiesbaden, Germany). As an inhibitor of low-density lipoprotein receptor–related proteins, we used the recombinant Mouse LRPAP Protein (LDL receptor-related protein-associated protein 1; also named receptor-associated protein (RAP), 50 ng/ml, Cat# 4480-LR, R&D Systems). RAP serves as a molecular chaperone for LDL receptor family proteins including VLDL and APOER2 and prevents interaction of ligands with these receptors. Therefore, RAP is used to block the canonical Reelin pathway by blocking Reelin from binding to VLDL and APOER2 (Bu and Schwartz 1998; Gong et al. 2007; Herz et al. 1991).

Fig. 2. Secreted Reelin rescues impaired Ca2+-frequency in RelncKO OTCs.

Fig. 2.

(A) A graphical flow chart for OTCs experimental procedure. (B) Schematic representation of the co-culture experimental approach. Left: Two co-cultured wt OTCs. Middle: A wt OTC co-cultured together with a RelncKO OTC. Right: Two co-cultured RelncKO OTCs. (C) Co-culture medium lysates from DIV14 OTCs (40 OTCs obtained from 5 mice for each experimental group) were analysed by western blot. (D) Quantification of the western blot 180-kDa Reelin signals. An actin antibody was used as loading control. The densiometric quantification showed a decreased Reelin protein level in the wt + RelncKO co-culture medium and almost complete absence in the RelncKO + RelncKO co-culture medium. One-way ANOVA followed by Holm-Sidak Multiple Comparison Test, ***p < 0.001 wt + RelncKO compared to wt + wt; ***P<0.001 wt + RelncKO compared to RelncKO + RelncKO. At 14 DIV, OTCs were loaded with OGB-1 AM and recorded. (E) The box-plot in the graph represents the values of maximal increase in Ca2+ signal amplitude, which shows no change in all experimental groups. (F and G) The box-plot shows a significant increase in Ca2+ frequency and Ca+2 transient half-width in RelncKO co-cultured OTCs. Note that the enhanced frequency and Ca+2 transients half-width observed in the RelncKO OTC are restored to a normal level when it is co-cultured together with a wt OTC. The number of recorded OTC is indicated above the box-plots in (E). One-way ANOVA on Ranks followed by Dunn’s Test, ***p < 0.001. The data is obtained from 3 independent OTCs preparations.

Expression plasmids and biolistic transfection

Transfection was performed using a Helios Gene Gun (Bio-Rad) as described previously (Wirth and Wahle 2003). In brief, cartridges were prepared by coating 10 mg gold particles (Ø = 1μm; Bio-Rad) with genetically encoded Ca2+ indicator pGP-CMV-GCaMP6s (GCaMP6s). GCaMP6s was a gift from Douglas Kim (RRID: Addgene_40753) (Chen et al. 2013). To prevent excitotoxicity during transfection, glutamate receptors were temporarily blocked with 3 mM kynuric acid (Cat# K3375, Sigma, Deisenhofen, Germany) and 50 mM APV (Cat# A5282, Sigma, Deisenhofen, Germany) before blasting. The blockers were washed out 3 hours after transfection.

Ca2+ imaging using Spinning disc laser microscopy

For studying network activity, Ca2+ imaging was performed in somatosensory cortex of supragranular layers II/III with the Ca2+ indicator Oregon Green BAPTA-1 Acetoxymethyl ester (OGB-1 AM) (Cat# O6807, Molecular Probes, Eugene, OR, USA). Acute slices (P14) or OTCs DIV14 were loaded according to our previously published protocol (Hamad et al. 2015). In brief, a solution of 20% PF127 (Cat# P2443, Sigma, Steinheim, Germany) dissolved in DMSO (w/v) (J.T. Baker) was prepared to dissolve OGB-1 AM. The final loading solution concentration was 1 μM OGB-1 AM. After loading, the slices were washed several times to remove excess dye and allowed to recover for an hour. The slices were then transferred to the recording chamber mounted on a fixed stage of an inverted microscope, and perfused with 95% O2, 5% CO2-bubbled artificial cerebrospinal fluid (ACSF; 3–5 ml/min) at 32 ± 2 °C. Composition of ACSF: (125 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgSO4, 25 mM NaHCO3, 1.25 mM NaH2PO4, 25 mM glucose, pH 7.4). The osmolality was 295±5 mOsm as determined with a cryoscopic osmometer (Osmomat 030, Gonotec, Berlin, Germany). Fluorometric Ca2+-recordings were made using a Visiscope spinning-disc confocal system CSU-W1 (Visitron, Munich, Germany) featuring a spinning disk unit CSU-W1-T2 and a sCMOS digital scientific grade camera (4.2 Mpixel rolling shutter version) on an inverted Nikon Ti-E motorized microscope using a CFI P-Fluor 20× objective (NA 0.5, WD = 2.10 mm). Images were acquired at 3 frames per second with exposure times of 330 ms with VisiView image acquisition software (Visitron, Munich, Germany). The Ca2+ dye OGB-1 AM and the biosensor GCaMP6s were excited at 488 nm. Emitted fluorescence was collected through ET 525/50 filter for OGB-1 AM and GCaMP6s. Fluorometric data are expressed as ΔF/F0 (background-corrected increase in fluorescence divided by the resting fluorescence). Raw data delivered in the form of a linear 16-bit intensity scale were plotted as fluorescence intensity versus time. Pyramidal cell or interneuron somata were chosen as the region of interest (ROI). The background fluorescence measured near a ROI was then subtracted from these raw data. The baseline fluorescence (F0) was calculated as an average of 20 frames in a time window without neuronal activity (as judged by visual inspection). Subsequently, data were normalized to the mean fluorescence intensities [ΔF/F0 =(F–F0)/F0], allowing the comparison of data across experiments. Spike (calcium transient) half-width was calculated as the width of the spike at half-maximal amplitude (Weir et al. 2014).

Immunohistochemistry and surface labelling

At DIV10, OTCs were fixed with 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer pH 7.4 and warmed to 36°C for 1 hour. After washing twice in TBS (Tris buffered Saline: 50 mM Tris, 150 mM NaCl, pH 7.6) and permeabilization in TBST (TBS, 0.1% Triton X), OTCs were blocked for 1 hour with 1% normal goat serum in TBST. Primary antibodies diluted in TBST were incubated for 24 h at room temperature. The following antibodies were used: Mouse anti-Reelin G10 (Cat# MAB5364, RRID: AB_2179313, 1:1000) , rabbit anti-Cre recombinase (Cat# 69050 , RRID: AB_2314229, 1:2000), rabbit anti-Cux-1 (CULT-1, Cat# ab140042, Abcam, Cambridge, UK, 1:500), rabbit anti-Wolframin 1 (WFS 1, Cat# 11558-1-AP, RRID: AB_2216046, 1:2000), mouse anti-Parvalbumin (Parv, Cat# 235, RRID: AB_10000343, 1:3000), rabbit anti-Glutamate Decarboxylase-65 (GAD65, Cat# G5038, RRID: AB_259920, 1:1000). After washing twice in TBS, the secondary antibodies were added accordingly: Goat anti mouse or goat anti rabbit biotinylated (Cat# E043201-8, Dako, Hamburg, Germany, 1:300). After several washes in TBS buffer, the slices were subjected to ABC-horseradish peroxidase method using diaminobenzidine as chromogen. For immunofluorescence, the slices were subsequently washed 3 × 15 min with TBST and incubated with secondary antibodies (anti-mouse IgG coupled to Alexa594 and anti-rabbit IgG coupled to Alexa488 in TBS (ThermoFisher, Darmstadt, Germany, 1:300) for 30 min at room temperature. After three repetitive washings with TBS-Tween, the OTCs were mounted with sRIMS mounting medium (70% sorbitol w/v in 0.02 M phosphate buffer with 0.01% sodium azide, pH 7.5). Fluorescence was analysed with the Visiscope spinning-disc confocal system as mentioned above. For GABABR1 und GABABR2 surface labelling, P14 wt and RelncKO acute slices were fixed with 4% paraformaldehyde. After several washes in TBS, a group of acute slices was permeabilized in TBST to detect total GABABRs and the other group was not permeabilized to detect only surface expression. The slices were blocked and incubated with the following primary antibodies that recognize only the N-terminus (extracellular) domain of GABABR1 (mouse anti-GABABR1, Cat# ab55051, RRID: AB_941703, 1:500) or the N-terminus (extracellular) domain of GABABR2 (Rabbit anti-GABABR2, Cat# 4819, RRID: AB_2108339, 1:750) for 24 h at room temperature. The slices were then washed and incubated with appropriate secondary fluorescent antibodies for 30 min. After repetitive washings with TBS, the slices were mounted with sRIMS buffer and mean fluorescence intensity was measured from layers II/III somatosensory cortices with the Visiscope spinning-disc confocal system.

Western blotting

Equal amounts of cortical tissue samples (22.5 μg) were homogenized in urea assay lysis buffer (100 mM Tris-HCl, pH= 7.5; 12 mM magnesium acetate tetrahydrate and 6M urea) with protease and phosphatase inhibitors and then centrifuged at 14,000 rpm for 15 min to remove debris and nuclei. The SDS loading buffer was run on a 10% SDS-polyacrylamide gel and transferred to a nitrocellulose membrane for 1 h 40 min in transfer buffer (25 mM Tris/Base, 192 mM glycine). Membranes were then blocked for 1 h at room temperature (RT) while shaking in blocking buffer with TBS (Cat# P/N 927-50000, Li-Cor, Bad Homburg, Germany). Membranes were incubated overnight (O/N) at 4 °C with the primary antibody and for 2h at RT with the secondary antibody. After each incubation step, membranes were washed for 3 × 15 min in TBS with 0.1% Tween 20. Membranes were imaged with the Odyssey immunoblot software (Lincoln). The Odyssey software system was also used for densitometric analysis. The following antibodies were used: Rabbit anti-GABABR2 (Cat# 4819, RRID: AB_2108339, 1:500) , mouse anti-GABABR1 (Cat# ab55051, Abcam, Cambridge, UK, 1:500), rabbit anti-GABABR2 p-Ser 783 (Cat# TA309142, OriGene Technologies, Herford, Germany, 1:1000), p-GABABR2 S892 (Cat# PPS073, RRID: AB_2108325, 1:1000), mouse anti-Reelin G10 ((Cat# MAB5364, RRID: AB_2179313, 1:1000), and ß-Actin (Cat# ab8227, RRID:AB_2305186,1:10000).

Statistical analysis

Statistical analysis was performed with Sigma Stat 12 (SPSS Incorporated). The data are presented as box plots with median (center line), minimum, and maximum (whiskers), and 25th–75th percentiles (box). Comparisons between two groups were performed with Students unpaired T-test when normality test (Shapiro-Wilk) passed, otherwise the Mann–Whitney test. Comparisons between groups larger than two were performed with one-way-ANOVA and a Holm-Sidak Multiple Comparison Test for post-hoc analysis if normality test passed. If normality failed, we run One-Way-Anova on Ranks followed by Tukey’s multiple comparison test for post hoc analysis to isolate the significant groups. If the sample sizes were unequal, the Dunn`s multiple comparison test was used to isolate the significant groups. Results were considered statistically significant at p<0.05.

Results

Cortical layering is not altered after postnatal loss of Reelin in RelncKO mice

To bypass the cortical layer malformations that are present in the reeler mutant, tamoxifen was fed to newborn pups (~P1) for 5 consecutive days. Around P14, animals were sacrificed, and sections of cortical tissue were subjected to immunohistochemical staining (Fig. S1). First, we confirmed that tamoxifen administration induces nuclear Cre activation and knockout of the floxed Reelin gene. We found that tamoxifen administration at P1 induced complete elimination of Reelin immunostaining at P14 (Fig. S1A). The pattern of immunostaining against wolframin (Wfs1), a protein expressed by layer II and IV neurons in the mouse somatosensory cortex, was indistinguishable from wt (Fig. S1B), while the layer-specific distribution of this protein is disrupted in the reeler cortex (Boyle et al. 2011). Next, we examined the distribution of cut-like homeobox 1 (Cux-1) protein, a transcription factor expressed in neurons throughout layers II–IV. In the cortex of adult reeler mice, most Cux-1-positive neurons are found in cortical layers V and VI and do not respect the strict boundary that characterizes wildtype cortical layering (Nieto et al. 2004). The distribution of Cux-1 immunostaining in the cortex of RelncKO mice was found in the supragranular layers II-IV and was indistinguishable from wt (Fig. S1C). We then examined the distribution of the fast-spiking interneuron marker Parvalbumin (Parv) and found it to be unchanged in the RelncKO when compared to wildtype mice (Fig. S1D). These findings confirm that postnatal Reelin elimination did not alter the distribution of layer specific expression markers in the neocortex.

Excessive Ca2+ spike frequency in early postnatally Reelin-deficient RelncKO mice

Using Ca2+ imaging, we compared spontaneous activity in acute slices prepared from wt and RelncKO littermates at P14 (both pup groups were fed with tamoxifen). In our experience (Hamad et al. 2015) as well as in other studies (Yuste et al. 2011), imaging a large network of neuronal populations loaded with the calcium indicator OGB-1 AM under a spinning-disk confocal microscope, equipped with fast cameras, can be used to image thousands of neurons simultaneously without significant photobleaching, with good signal-to-noise ratio and minimized cellular damage because it does not require electrodes penetrating the tissue. To ensure that tamoxifen per se did not alter basic synaptic transmission, we recorded Ca2+ amplitude and frequency in DIV14 (days in vitro 14) OTCs loaded with OGB-1 AM from wt mice which were stimulated for 5 consecutive days either with 4-hydroxytamoxifen (4-OHT) or vehicle (DMSO) as a control group (Fig. S2). Neither 4-OHT nor vehicle groups showed any difference in Ca2+ amplitude, frequency or Ca2+ transient half-width when compared to the untreated wt control group (Fig. S2). Next, we compared Ca2+ signal amplitude, frequency and Ca2+ transient half-width in wt and RelncKO slices using the Ca2+ indicator OGB-1 AM (Fig. 1B-F). Ca2+ amplitudes were not altered in RelncKO when compared to the wt control group (Fig. 1D). Strikingly, the Ca2+ frequency and Ca2+ transient half-width were significantly increased in RelncKO (Fig. 1E and F). Recordings were performed in acute slices prepared at P14 and transfected with a genetic construct encoding the Ca2+ indicator GCaMP6s (Chen et al. 2013). GCaMP6s is very sensitive to Ca2+ changes and we found it to be distributed in soma, dendrites and axon (Fig. 1G). Criteria to distinguish pyramidal cells and interneurons were based on dendritic and axonal patterns (Hamad et al. 2011; Hamad et al. 2014; Karube et al. 2004; Kawaguchi et al. 2006). To confirm the cell type, after Ca2+ recording, acute slices were fixed and stained against glutamate decarboxylase-65 (GAD-65) which labels the GABA biosynthesis enzyme in the soma of all GABAergic interneurons but does not label glutamatergic pyramidal cells (Fig. S3). Our results confirmed an unchanged amplitude in Relnwt compared to RelncKO in both pyramidal cells and interneurons (Fig. 1H) and revealed an enhanced frequency and Ca2+ transient half-width in both pyramidal cells and interneurons in the RelncKO (Fig. 1I and J), suggesting that RelncKO mice exhibit defects at the presynaptic level. Moreover, Ca2+ amplitude and Ca2+ transient half-width did not differ between pyramidal cells and interneurons in both wt and RelncKO slices during GCaMP6s recordings, confirming a previously published study (Weir et al. 2014). Therefore, the subsequent recording experiments were performed with the calcium dye OGB-1 AM.

Wildtype Reelin rescues Ca2+ frequency in RelncKO neurons

Next, we investigated whether secreted Reelin from wt OTCs might rescue the abnormal neuronal activity observed in the RelncKO OTCs. To address this question, we co-cultured OTCs as follows: wt + wt, or RelncKO + RelncKO, or wt + RelncKO (Fig. 2B). To detect the abundance of secreted Reelin in the culture medium under these three conditions, we quantified secreted Reelin protein with western blot from culture medium. As expected, the amount of secreted Reelin was abundant in the wt + wt, a lesser amount was detectable in the wt + RelncKO, whereas Reelin was almost undetectable in the RelncKO + RelncKO co-culture medium (Fig. 2C and D). Ca2+ recordings experiments showed that the Ca2+ amplitude did not change under any of the three experimental conditions (Fig. 2E) confirming our interpretation that Reelin does not affect postsynaptic activity. However, in the RelncKO OTCs co-cultured with wt, the Ca2+ frequency and Ca2+ transient half-width in the recorded RelncKO OTC was reduced to the same level as in the wt OTC (Fig. 2F and G). These results suggest that Reelin secreted from wt OTCs into the incubation medium restored presynaptic activity in RelncKO OTCs to a basic level comparable to the wt control group.

GABABR function is impaired in RelncKO mice

GABABRs are present in GABAergic neuronal terminals (as autoreceptors) and in glutamatergic and other terminals (heteroreceptors) (Benarroch 2012). Around the second postnatal week, the only source of Reelin in the neocortex are inhibitory interneurons (Pohlkamp et al. 2014). We speculated that the increased Ca2+ spiking frequency in RelncKO mice in pyramidal cells and interneurons that we observed, was likely due to a defect of GABABR function at the GABAergic or glutamatergic presynaptic terminal. If presynaptic GABABRs at the GABAergic neuronal terminals were defective in RelncKO mice, activated GABABRs would no longer be able to block Ca2+ channels because presynaptic GABAB receptors inhibit N type (Cav2.2) or P/Q type (Cav2.1) Ca2+ channels, resulting in reduced neurotransmitter release (Benarroch 2012). In turn, Ca2+ channels trigger the release of GABA, and thereby inhibit neighbouring cells. However, RelncKO mice exhibited a higher Ca2+ frequency when compared to wt control (Fig. 1), suggesting that presynaptic GABABRs at GABAergic neuronal terminals were not defective in RelncKO mice. Therefore, we tested a second possibility, i.e. defective presynaptic GABABRs at glutamatergic terminals in RelncKO mice. To test this possibility, we recorded wt and RelncKO OTCs in the presence of the AMPA- and kainate receptor blocker CNQX and the NMDARs antagonist APV at DIV14 (Fig. S4). Bath application of 10 μM CNQX immediately decreased the Ca2+ amplitude, frequency and Ca2+ transient half-width in RelncKO to the same extent as in the wt control group (Fig. S4 A and B). Similarly, APV application elicited the same effect (Fig. S4 D-F). The observation that the excessive Ca2+ frequency in the RelncKO can be blocked with CNQX or APV suggests that glutamatergic signaling in the absence of Reelin is still functional. Taken together, we conclude from our findings that most likely GABABRs at glutamatergic presynaptic terminals are defective in the RelncKO. Moreover, We preclude a possible defect of GABABRs at the postsynaptic site because no significant change in the Ca2+ amplitude was observed (Fig. 1).

To examine a possible crosstalk between Reelin signaling and GABABR function, we prepared OTCs from P0 mice. OTCs were treated with 4-OHT at DIV1-5 to induce Reelin deficiency. Subsequent Reelin knockout, Ca2+-recordings were performed around DIV14 (Fig. 3). First, to confirm conditionally induced Reelin knockout, OTCs were fixed at DIV14 and immunostained against Cre-recombinase and Reelin (Fig. S5). While pronounced Reelin staining was seen in wt OTCs, it was absent in Relncko OTCs. Bath application of the GABABR agonist baclofen (10 μM) immediately activated GABABRs and strongly decreased the Ca2+ amplitude by 6-fold in wt OTCs, but to a lesser extent (1.6-fold) in RelncKO OTCs (Fig. 3A), suggesting that postsynaptic GABABRs were still functioning in RelncKO OTCs. However, we do not preclude a postsynaptic functional difference between wt and RelncKO. Moreover, baclofen induced a profound reduction of the Ca2+ frequency and Ca2+ transient half-width in wt OTCs (Fig. 3B and C and Movie S1), but no effect was observed in RelncKO OTCs (Fig. 3B, C and Movie S2). This suggests an altered GABABR function at presynaptic sites in RelncKO, probably due to a lack of trafficking and localization of GABABRs at the plasma membrane in RelncKO mice. Strikingly, the GABABR antagonist CGP35348 (10 μM) did not influence the Ca2+ amplitude, neither in wt nor in RelncKO OTCs (Fig. 3D). However, blockade of GABABRs in wt OTCs dramatically increased the Ca2+ signaling frequency and Ca2+ transient half-width in wt but not in RelncKO OTCs (Fig. 3E and F). Taken together, these results indicate a presynaptic dysfunction of GABABRs in the RelncKO OTCs.

Fig. 3. GABABRs are dysfunctional in RelncKO.

Fig. 3.

To test the functionality of the GABABRs at DIV14, OTCs were loaded with OGB-1 AM, spontaneous activity was first recorded and then the GABABR agonist baclofen (10 μm) was added. In each experiment, OTCs were prepared from 5 wt and 5 RelncKO mice. (A): The application of baclofen immediately activates GABABRs and thereby strongly decreases Ca+2 amplitude in wt OTCs (One-way ANOVA on Ranks followed Tukey’s Test, ***p < 0.001) but to a lesser extent in RelncKO OTCs (*p < 0.05). Ca2+-frequency (B) and Ca2+ transient half-width (C) were significantly decreased in the wt but not in RelncKO OTCs (One-way ANOVA on Ranks followed Tukey’s Test, ***p < 0.001). The GABABR antagonist CGP35348 (10 μM) did not alter Ca2+ amplitudes in both wt and RelncKO OTCs (D). The application of CGP35348 significantly enhanced Ca2+ frequency (E) and Ca2+ transient half-width (F) in wt but not RelncKO OTCs. One-way ANOVA on Ranks followed by Dunn’s Test, ***p < 0.001. The number of OTCs analysed is indicated above the box-plot in (D). The data is obtained from 3 independent OTCs preparations.

Presynaptic GABABRs are modulated by Reelin signaling

Based on our observation that presynaptic GABABRs do not properly function in the absence of Reelin, we wondered whether the function of GABABRs might be modulated by canonical Reelin signaling. To address this question, we treated OTCs with RAP, an inhibitor of low-density lipoprotein receptor–related proteins (including VLDL and APOER2; (Herz et al. 1991; Willnow et al. 1996)). Reelin acts via binding to VLDLR and ApoER2 to regulate Dab1 tyrosine phosphorylation (Cooper and Howell 1999; Trommsdorff et al. 1999). We have found that chronic RAP treatment (50 ng/ml, over 5 days) did not affect the Ca2+ amplitude in RelncKO and wt OTCs (Fig. 4A). However, RAP blockade in wt OTCs enhanced the Ca2+ frequency and Ca2+ transient half-width to a comparable extent as seen in the RelncKO without RAP treatment (Fig. 4B and C). As expected, RelncKO OTCs treated with RAP did not exhibit any changes in frequency and Ca2+ transient half-width (Fig. 4B and C). These observations suggest that GABABRs require crosstalk with Reelin signaling for their proper function.

Fig. 4. Effect of chronic blockade with the LDL-receptor chaperone RAP.

Fig. 4.

RelncKO or wt OTCs chronically treated with RAP (50 μg) were loaded with OGB-1 AM and recorded. In each experiment, OTCs were prepared from 5 wt and 5 RelncKO mice. Control wt or RelncKO OTCs were treated with H2O. (A) RAP blockade did not affect Ca2+-amplitude in wt and RelncKO OTCs. However, RAP significantly increased Ca2+-frequency (B) and Ca2+-transient half-width (C) in wt but not RelncKO OTCs. One-way ANOVA on Ranks followed by Dunn’s Test, ***p < 0.001. The number of OTCs analysed is indicated above the box-plots in (A). The data is obtained from 3 independent OTCs preparations.

Reelin activates members of Src family tyrosine kinases (SFKs) via ApoER2 and VLDLR and Dab1 (Bock and Herz 2003; Cooper and Howell 1999). Therefore, we addressed the question whether inhibition of Src family kinases with the pharmacological blocker PP2 might affect GABABR function. Our results show that the application of 1 μM PP2 at DIV14 did not alter the Ca2+ amplitude neither in wt nor in RelncKO OTCs (Fig. 5A). In turn, the Ca2+ frequency and Ca2+ transient half-width were increased in wt only but not RelncKO OTCs (Fig. 5B and C). To test whether the inhibition of Src family kinases with the pharmacological blocker PP2 might also affect GABABR surface expression, OTCs from wt and RelncKO mice were treated with 1 μM PP2 and immunostained against GABABR1 and GABABR2 under non-permeabilized condition to detect their surface expression (Fig. S6). The surface expression of GABABR1 and GABABR2 was significantly reduced in wt OTC but remained unaltered in the RelncKO. Together, these results suggest that Reelin signaling through Src is important to maintain GABABRs function and surface expression. In line with these findings, a previous study had shown that the expression of SNAP25, a protein that is involved in the control of transmitter release, was decreased in the hippocampus of reeler mutant mice, but not altered in ApoER2-, VLDLR-, or Dab1-deficient mice (Hellwig et al. 2011). Moreover, GABABRs were found to be downregulated in the reeler mutant (Cremer et al. 2011). Taken together, our findings suggest that presynaptic GABABR function is modulated through the Reelin signaling cascade.

Fig. 5. Effect of acute Src kinase inhibition on wt and RelncKO Ca2+ activity.

Fig. 5.

Acute application of PP2 (1 μM) did not affect Ca2+-amplitude in both wt and RelncKO OTCs (A). However, PP2 application enhances Ca2+ frequency (B) and Ca2+ transient half-width (C) in wt but not RelncKO OTCs (B). In each experiment, OTCs were prepared from 5 wt and 5 RelncKO mice. One-way ANOVA on Ranks followed by Dunn’s Test, ***p < 0.001. The number of OTCs analysed is indicated above the box-plots. The data is obtained from 3 independent OTCs preparations.

Reelin signaling alters GABABR2 cell surface expression and its phosphorylation at S783 and S892

Previous studies have demonstrated that GABABRs do not undergo agonist-induced internalization (Terunuma, Pangalos et al. 2010), and that GABABR cytoplasmic domains contain multiple phosphorylation sites (Couve et al. 2002; Fairfax et al. 2004). To find out whether Reelin deficiency might affect GABABR cell surface expression, we performed immunofluorescence staining of GABABR1 and GABABR2 with specific antibodies that recognize only the extracellular N-terminal domain of the receptor subunits (Fig. 6). Mean fluorescence intensity analysis revealed that both GABABR1 and GABABR2 surface staining was significantly reduced in non-permeabilized cells of RelncKO acute slices in comparison to wt (Fig. 6), suggesting a role of Reelin in regulating GABABR cell surface expression. Next, we investigated whether secreted Reelin from wt OTCs might rescue the reduction of GABABR1 and GABABR2 surface expression in the RelncKO. To address this question, we co-cultured OTCs from wt + RelncKO (Fig. S7). Our results show that Reelin secreted from wt OTCs into the incubation medium maintained GABABR1 and GABABR2 expression in RelncKO at a level comparable to the wt control group.

Fig. 6. Surface GABABR1 and GABABR2 expression are reduced in the RelncKO slices.

Fig. 6.

Acute slices (P14) from wt and RelncKO mice were immunostained against total (permeabilized) and surface (non-permeabilized) GABABR1 and GABABR2 expression. In each experiment, slices were prepared from 5 wt and 5 RelncKO mice. Confocal image example at 40 x magnification from layers II/III somatosensory cortices of wt (A) and RelncKO (B) acute slices stained against GABABR1 or GABABR2 (C and D) under permeabilization condition to detect total receptor expression. Confocal image example of wt (E) and RelncKO (F) acute slices stained against GABABR1 or GABABR2 (G and H) under non-permeabilization condition for receptor surface expression. (I) The box-plots represent values of average pixel intensity of total (permeabilized) and surface (non-permeabilized) GABABR1 expression. (J) The box-plots represent values of average pixel intensity of total (permeabilized) and surface (non-permeabilized) GABABR2 expression. One-way ANOVA on Ranks followed by Dunn’s Test, ***p < 0.001. The number of acute slices analysed is indicated above the box-plots. The data is obtained from 3 ex-vivo acute slice preparations. Scale bar: 10 μm.

Finally, we performed western blotting, to assess the amount of expressed GABABR1 and GABABR2 protein, which however, did not differ significantly between wt and RelncKO, though the amount of both receptors showed a tendency to decrease in the RelncKO (Fig. 7A and B). To find out whether Reelin deficiency might affect GABABR phosphorylation, we analysed cortical lysates from wt and RelncKO P14 mice by western blotting with antibodies against GABABR phosphorylation sites. GABABR2 phosphorylation at Ser892 is mediated by cyclic AMP (cAMP)–dependent protein kinase (PKA) and stabilizes cell surface expression and coupling to G-proteins of the receptors (Couve et al. 2002). Western blotting revealed that in Reelin deficient tissue, S892 phosphorylation of GABABR2 was significantly reduced when compared to wt (Fig. 7C), suggesting that Reelin signaling is important to stabilize GABABR2 function at the cell surface. Another GABABR2 phosphorylation site at S783 is required for degradation, and its phosphorylation is mediated by 5ʹ-AMP-dependent protein kinase (AMPK) (Terunuma, Vargas et al. 2010). GABABR2 recycling and degradation is controlled via phosphorylation site S783 (Gassmann and Bettler 2012). Western blot analysis revealed that GABABR2 phosphorylation at S783 in RelncKO mice was in creased when compared to wt, and that phosphorylated GABABR2s were degraded in RelncKO mice only (Fig. 7D). Taken together, these findings indicate that Reelin is required to stabilize the cell surface expression of functional GABABR2 receptors, probably by inhibiting receptor degradation.

Fig. 7. Reelin signaling regulates GABAB-receptor phosphorylation.

Fig. 7.

Cortical lysates from P14 wt and RelncKO mice were analysed by western blot (n = 6 animals from each group; The data is obtained from 3 different tissue explants). Total GABABR1 (A) and GABABR2 (B) were unaltered in RelncKO in comparison to wt control. (C): Phosphorylation of GABABR2 at S892 was significantly reduced in RelncKO (T-test, ***p < 0.001), whereas phosphorylation at S783 was significantly increased (D) when compared to wt (T-test, ***p < 0.001), and appearance of several bands suggests proteolysis of the receptor (Gassmann and Bettler 2012; Maier et al. 2010).

GABABR intracellular signaling via Gαi/o proteins is affected in RelncKO mice

To further investigate a potential crosstalk between Reelin, GABABR signaling and G-protein coupled receptors, we recorded OTCs in the presence of pertussis toxin (PTX). Stimulation of GABABRs with baclofen inhibits adenylyl cyclase (Xu and Wojcik 1986), which in turn can be blocked by pertussis toxin (PTX), known to inhibit G-protein function (Karbon and Enna 1985; Nishikawa and Kuriyama 1989). Application of PTX at DIV14 enhanced the Ca2+ amplitude, frequency and Ca2+ transient half-width in wt but not in RelncKO OTCs (Fig. S8). These results further support the interpretation that Ca2+-signalling is unaltered by the treatment in RelncKO OTCs because GABABR receptors are degraded in the absence of Reelin. It also confirms that Reelin is important to maintain proper GABABR signaling.

Discussion

In the present study, we characterized a novel role of Reelin in early postnatal cortical function. We found that postnatally induced Reelin deficiency caused abnormal Ca2+ spike frequency and Ca2+ transient half-width in cortical neurons. RAP blockade of Reelin binding to its receptors ApoER2 and VLDLR mimicked this effect. There are no specific selective antagonists for ApoER2 and VLDLR, therefore we used RAP to broadly block LRP family members. Co-culture of RelncKO OTCs with Reelin secreting wt OTCs rescued deficient network activity in RelncKO OTCs. While the GABABR agonist baclofen failed to activate GABABRs, the GABABR antagonist CGP35348 failed to inhibit GABABRs in RelncKO OTCs, indicating deactivation and/or degradation of GABABRs in RelncKO OTCs. Immunostaining of non-permeabilized cells with antibodies against GABABR1 and GABABR2 extracellular domains was significantly reduced in RelncKO slices in line with our pharmacological experiments, and confirming a previous study that reported on a downregulation of GABABRs in the reeler mutant (Cremer et al. 2011). When analysing cortical tissue of conditionally induced Reelin deficient mice by western blotting, we found a decreased GABABR2 phosphorylation at S892 and an increased phosphorylation at S783, both indicative of GABABR2 degradation (Gassmann and Bettler 2012), and proteolytic processing of GABABR2. Accordingly, in RelncKO slices we observed a decrease in surface expression of GABABR1 (approx. 35% decrease) and GABABR2 (approx. 39% decrease) respectively. The enhanced Ca+2 frequency in the RelncKO slices can be attributed to the degradation (downregulation) of the GABABRs at the presynaptic sites. The main function of presynaptic GABABRs at the presynaptic site is to inhibit calcium channels, which results in inhibition of neurotransmitter release (Benarroch 2012). Together, our findings suggest a novel role for Reelin in controlling cortical neuronal network maturation, by regulating Ca2+ spiking in glutamatergic neurons via presynaptic GABABRs.

Prolonged NMDA-R stimulation triggered both the endocytosis of GABABRs (Terunuma, Vargas et al. 2010) and activation of PP2A. PP2A in turn favors dephosphorylation of S783 in GABABR2 and redirection of the endocytosed pool from recycling to degradation. However, Surprisingly, despite the observed dephosphorylation of S783 in GABAergic neurons, no increase in the lysosomal degradation of GABABRs has been observed by (Padgett et al. 2012). The identification of S783 on the GABABR2 subunit as an AMPK substrate points to a link between the induction of ischemia and increased phosphorylation of GABABRs in the hippocampus (Kuramoto et al. 2007). The increase in GABAB receptor phosphorylation, evident during ischemia, could provide a potentially neuroprotective mechanism that may limit neuronal exposure to excitotoxicity. In absence of Reelin, we also observed enhanced Ca2+ signalling in the RelncKO and increased phosphorylation at Ser783, which might similarly be important to protect neurons from excitotoxicity.

By performing immunohistochemical staining with antibodies against layer-specific markers, we confirm that cortical neurons in postnatal RelncKO did not alter their characteristic layer specific marker expression in the absence of Reelin (Boyle et al. 2011). There are two populations of Reelin expressing neurons in the neocortex. At early embryonic stages, Reelin is secreted by Cajal-Retzius (CR) cells. The number of CR cells declines postnatally, and these cells disappear almost completely around P14 by undergoing selective cell death through apoptosis (Anstötz et al. 2014). Moreover, almost all GABAergic interneurons in the neonatal cortex express Reelin, suggesting that in the current study Reelin was mainly expressed by interneurons.

A role of Reelin in modulating glutamatergic activity has been previously reported (Chen et al. 2005). Reelin-haploinsufficiency has been shown to disrupt the developmental course of GABA excitatory/inhibitory balance (Bouamrane et al. 2016). In the current experiments, we studied spontaneous neuronal calcium activity in the RelncKO compared to wt littermates. While the Ca2+ amplitude was unaltered in RelncKO, the frequency of Ca2+ spiking and Ca2+ transient half-width was dramatically increased in RelncKO when compared to wt. The Ca2+ spike half-width narrows around the second postnatal week (14DIV or P14) and this observation has been previously attributed to an increase in cell size and maturation of ion channels (Gold et al. 2007). Thus, the increased Ca2+ spikes half-width in RelncKO may suggest an immature ion channels condition in these mice. Along this line, related observations were reported in the reeler hippocampus. Thus, using electron microscopy, it has been shown that the number of presynaptic vesicles was significantly increased in hippocampal CA1 synapses of reeler mutant mice when compared to wt (Hellwig et al. 2011). In contrast, acute Reelin application to dissociated hippocampal neurons enhanced spontaneous neurotransmitter release without affecting properties of evoked neurotransmission (Bal et al. 2013). The discrepancy here may be due to the different models and methodologies used. For instance, acute application of 5 nM Reelin (Bal et al. 2013) versus analysis of the reeler mutant (Hellwig et al. 2011) or the RelncKO (present study). In neocortical neurons, neurotransmitter release is controlled by GABABR function (see Introduction). Moreover, perturbations of GABAB receptor signaling during development may shift the excitatory/inhibitory balance, culminating in various neurological dysfunctions, including typical and atypical absence seizures (Han et al. 2012). To find out whether Reelin function might interfere with GABABR function, we manipulated GABABR physiology in RelncKO tissue using pharmacological agents. Our observation that a GABABR agonist failed to activate GABABRs and an antagonist failed to inhibit GABABRs in the RelncKO, points to a novel function of Reelin as a modulator of GABABRs during early cortical function. Taken together, our data suggest that in the absence of Reelin, GABABRs are downregulated, as shown by GABABR cell surface immunolabelling experiments, and by western blotting that revealed an altered GABABR phosphorylation status as well as proteolytic receptor processing.

Next, we investigated possible mechanisms underlying cross-talk of Reelin and GABABR signaling. Binding of Reelin to its receptors induces phosphorylation of Dab1 protein by Src kinase (Bock and Herz 2003). Blocking of wt OTCs with a Src inhibitor increased the Ca2+ signaling frequency to a comparable level as in RelncKO. Moreover, the Src inhibitor decreased GABABRs surface expression in wt slices but it did not affect GABABRs surface expression in the RelncKO. These observations suggest that Reelin signaling through Src is important to maintain GABABRs function. Src may directly interact with the α subunits of G-proteins (Ma et al. 2000) and recently it has been shown that Src/Gαo interactions provide evidence for a novel type of cross-talk between a non-receptor tyrosine kinase stimulated by Reelin and heterologous G protein-coupled receptors (GPCR) (Cho et al. 2015). Since GABABRs, are members of the G-protein coupled receptors (GPCRs), it is very well possible that metabotropic GABABRs are modulated by Reelin through Src-kinase.

Stimulation of GABABRs with baclofen can inhibit both basal, and forskolin stimulated adenylyl cyclase (Xu and Wojcik 1986), which in turn can be blocked by pertussis toxin (PTX), reflecting the involvement of the Giα- and Goα- subunit of the G-protein (Karbon and Enna 1985; Nishikawa and Kuriyama 1989). Moreover, immunoprecipitation assays disclosed the possibility that Reelin might increase the active forms of both Src and Gαo and promote their direct association (Cho et al. 2015). Thus, our finding that PTX increases Ca2+ frequency in wt OTCs but not in RelncKO, indicates the possibility of a disrupted Src-Gαi/o interaction in the absence of Reelin. For instance, based on our experiments it appears more likely that reduced cell surface expression of GABABR is the reason why Ca2+ signalling is unaltered in RelncKO OTCs after PTX application.

Functional deficits associated with decreased Reelin expression have often been attributed to the well-known developmental neuronal migration defects in Reelin deficient mice (Eastwood and Harrison 2003). Moreover, both Reelin deficiency and cortical network dysrhythmias caused by aberrant interneuron activity were also discussed as possible factors contributing to cognitive and behavioural deficits in Alzheimer disease (AD) (Palop and Mucke 2016; Xiao et al. 2017). Besides Reelin, also different ApoE isoforms act as lipoprotein receptor ligands and are known to influence AD pathogenesis, with ApoE4 being the most important genetic risk factor for AD (Huang et al. 2017). GABABRs were repeatedly shown to be implicated in synaptic plasticity (Davies et al. 1991; Mott and Lewis 1991). Until recently, it remained unclear whether GABABRs can influence neuronal plasticity through GABABRs signaling. It has been demonstrated that G-protein mediated signaling through GABABRs delays the recruitment of synaptic vesicles during sustained activity and after short-term depression (Sakaba and Neher 2003). This delay occurs through a reduction of cAMP, which in turn blocks the stimulatory effect of the increased Ca2+ concentration on vesicle recruitment (Sakaba and Neher 2003). In conclusion, we provide evidence for a novel role of Reelin signaling in controlling early neuronal network activity by regulating neurotransmitter release through GABABRs.

Supplementary Material

figures S1-S8

Fig. S1. Expression of neocortical markers in wt and RelncKO mice.

Fig. S2. Effect of chronic 4-OHT treatment on Ca2+ spontaneous activity in OTCs

Fig. S3. Immunolabelling of GCaMP6s transfected cells with GAD-65.

Fig. S4. Effect of glutamatergic transmission blockade on spontaneous activity in RelncKO mice.

Fig. S5. Cre recombinase and Reelin immunostaining from DIV14 4-OHT treated OTCs.

Fig. S6. PP2 reduces surface GABABR1 and GABABR2 expression in wt OTCs.

Fig. S7. Secreted Reelin rescues surface expression of GABABR2 in RelncKO OTCs.

Fig. S8. Effect of acute PTX application on Ca2+ signaling in RelncKO OTCs.

movie S1

Movie S1. Baclofen inhibits Ca2+ spike activity in wt OTCs.

Download video file (12.1MB, avi)
movie S2

Movie S2. Baclofen did not affect Ca2+ spike activity in RelncKO OTCs.

Download video file (11.7MB, avi)

Acknowledgments

Funding: This work was supported by the National Institutes of Health grant R37 HL63762, R01 NS093382, R01 NS108115, and RF1 AG053391, the Consortium for Frontotemporal Dementia Research; the Bright Focus Foundation and a Harrington Innovator Award to J. H., E. F. was supported by FoRUM of the Ruhr-Universität Bochum.

Abbreviations:

ACSF

artificial cerebrospinal fluid

ANOVA

Analysis of variance

APV

(2R)-amino-5-phosphonopentanoate

CNQX

6-cyano-7-nitroquinoxaline-2,3-dione

Cux-1

cut-like homeobox 1

DIV

Days in vitro

DAB1

Disabled-1

F0

baseline fluorescence

GAD65

Glutamate Decarboxylase-65

GABA

gamma-aminobutyric acid

LRPAP Protein = RAP

LDL receptor-related protein-associated protein 1

OGB-1 AM

Oregon Green BAPTA-1 Acetoxymethyl

OTCs

Organotypic cultures

4-OHT

(Z)-4-hydroxytamoxifen

PFA

paraformaldehyde

P

postnatal day

Parv

Parvalbumin

PTX

pertussis toxin

RelncKO

Reelin conditional knock-out mice

ROI

region of interest

RRID

research resource identifier

TBS

Tris buffered Saline

WFS

Wolframin 1

WT

Relnflox/flox wildtype

Footnotes

Competing interests: The authors declare that they have no competing interests.

Data and materials availability: The RelncKO mice require a material transfer agreement from the University of Texas Southwestern Medical Center.

References

  1. Anstötz M, Cosgrove KE, Hack I, Mugnaini E, Maccaferri G and Lübke JHR (2014) Morphology, input-output relations and synaptic connectivity of Cajal-Retzius cells in layer 1 of the developing neocortex of CXCR4-EGFP mice. Brain Struct Funct 219, 2119–2139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bal M, Leitz J, Reese AL, Ramirez DMO, Durakoglugil M, Herz J, Monteggia LM and Kavalali ET (2013) Reelin mobilizes a VAMP7-dependent synaptic vesicle pool and selectively augments spontaneous neurotransmission. Neuron 80, 934–946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ben-Ari Y, Gaiarsa J-L, Tyzio R and Khazipov R (2007) GABA. Physiol Rev 87, 1215–1284. [DOI] [PubMed] [Google Scholar]
  4. Ben-Ari Y, Woodin MA, Sernagor E, Cancedda L, Vinay L, Rivera C, Legendre P, Luhmann HJ, Bordey A, Wenner P, Fukuda A, van den Pol AN, Gaiarsa J-L and Cherubini E (2012) Refuting the challenges of the developmental shift of polarity of GABA actions. Front Cell Neurosci 6, 35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Benarroch EE (2012) GABAB receptors. Neurology 78, 578–584. [DOI] [PubMed] [Google Scholar]
  6. Bettler B, Kaupmann K, Mosbacher J and Gassmann M (2004) Molecular structure and physiological functions of GABA(B) receptors. Physiol Rev 84, 835–867. [DOI] [PubMed] [Google Scholar]
  7. Bock HH and Herz J (2003) Reelin activates SRC family tyrosine kinases in neurons. Curr Biol 13, 18–26. [DOI] [PubMed] [Google Scholar]
  8. Bock HH and May P (2016) Canonical and Non-canonical Reelin Signaling. Front Cell Neurosci 10, 166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bouamrane L, Scheyer AF, Lassalle O, Iafrati J, Thomazeau A and Chavis P (2016) Reelin-Haploinsufficiency Disrupts the Developmental Trajectory of the E/I Balance in the Prefrontal Cortex. Front Cell Neurosci 10, 308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Boyle MP, Bernard A, Thompson CL, Ng L, Boe A, Mortrud M, Hawrylycz MJ, Jones AR, Hevner RF and Lein ES (2011) Cell-type-specific consequences of Reelin deficiency in the mouse neocortex, hippocampus, and amygdala. J Comp Neurol 519, 2061–2089. [DOI] [PubMed] [Google Scholar]
  11. Bu G and Schwartz AL (1998) RAP, a novel type of ER chaperone. Trends Cell Biol 8, 272–276. [DOI] [PubMed] [Google Scholar]
  12. Caviness VS (1976) Patterns of cell and fiber distribution in the neocortex of the reeler mutant mouse. J Comp Neurol 170, 435–447. [DOI] [PubMed] [Google Scholar]
  13. Caviness VS (1982) Neocortical histogenesis in normal and reeler mice. Brain Res 256, 293–302. [DOI] [PubMed] [Google Scholar]
  14. Caviness VS and Sidman RL (1973) Time of origin or corresponding cell classes in the cerebral cortex of normal and reeler mutant mice. J Comp Neurol 148, 141–151. [DOI] [PubMed] [Google Scholar]
  15. Chen T-W, Wardill TJ, Sun Y, Pulver SR, Renninger SL, Baohan A, Schreiter ER, Kerr RA, Orger MB, Jayaraman V, Looger LL, Svoboda K and Kim DS (2013) Ultrasensitive fluorescent proteins for imaging neuronal activity. Nature 499, 295–300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Chen Y, Beffert U, Ertunc M, Tang T-S, Kavalali ET, Bezprozvanny I and Herz J (2005) Reelin modulates NMDA receptor activity in cortical neurons. J Neurosci 25, 8209–8216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Cho S-K, Choi J-M, Kim J-M, Cho JY, Kim S-S, Hong S, Suh-Kim H and Lee Y-D (2015) AKT-independent Reelin signaling requires interactions of heterotrimeric Go and Src. Biochem Biophys Res Commun 467, 1063–1069. [DOI] [PubMed] [Google Scholar]
  18. Cooper JA and Howell BW (1999) Lipoprotein receptors. Cell 97, 671–674. [DOI] [PubMed] [Google Scholar]
  19. Couve A, Thomas P, Calver AR, Hirst WD, Pangalos MN, Walsh FS, Smart TG and Moss SJ (2002) Cyclic AMP-dependent protein kinase phosphorylation facilitates GABA(B) receptor-effector coupling. Nat Neurosci 5, 415–424. [DOI] [PubMed] [Google Scholar]
  20. Cremer CM, Lübke JHR, Palomero-Gallagher N and Zilles K (2011) Laminar distribution of neurotransmitter receptors in different reeler mouse brain regions. Brain Struct Funct 216, 201–218. [DOI] [PubMed] [Google Scholar]
  21. Curran T and D'Arcangelo G (1998) Role of reelin in the control of brain development. Brain Res Brain Res Rev 26, 285–294. [DOI] [PubMed] [Google Scholar]
  22. D'Arcangelo G, Homayouni R, Keshvara L, Rice DS, Sheldon M and Curran T (1999) Reelin is a ligand for lipoprotein receptors. Neuron 24, 471–479. [DOI] [PubMed] [Google Scholar]
  23. Davies CH, Starkey SJ, Pozza MF and Collingridge GL (1991) GABA autoreceptors regulate the induction of LTP. Nature 349, 609–611. [DOI] [PubMed] [Google Scholar]
  24. Dazzo E, Fanciulli M, Serioli E, Minervini G, Pulitano P, Binelli S, Di Bonaventura C, Luisi C, Pasini E, Striano S, Striano P, Coppola G, Chiavegato A, Radovic S, Spadotto A, Uzzau S, La Neve A, Giallonardo AT, Mecarelli O, Tosatto SCE, Ottman R, Michelucci R and Nobile C (2015) Heterozygous reelin mutations cause autosomal-dominant lateral temporal epilepsy. Am J Hum Genet 96, 992–1000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Eastwood SL and Harrison PJ (2003) Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia. Mol Psychiatry 8, 769, 821–31. [DOI] [PubMed] [Google Scholar]
  26. Fairfax BP, Pitcher JA, Scott MGH, Calver AR, Pangalos MN, Moss SJ and Couve A (2004) Phosphorylation and chronic agonist treatment atypically modulate GABAB receptor cell surface stability. J Biol Chem 279, 12565–12573. [DOI] [PubMed] [Google Scholar]
  27. Fukuda A, Mody I and Prince DA (1993) Differential ontogenesis of presynaptic and postsynaptic GABAB inhibition in rat somatosensory cortex. J Neurophysiol 70, 448–452. [DOI] [PubMed] [Google Scholar]
  28. Gassmann M and Bettler B (2012) Regulation of neuronal GABA(B) receptor functions by subunit composition. Nat Rev Neurosci 13, 380–394. [DOI] [PubMed] [Google Scholar]
  29. Gold C, Henze DA and Koch C (2007) Using extracellular action potential recordings to constrain compartmental models. J Comput Neurosci 23, 39–58. [DOI] [PubMed] [Google Scholar]
  30. Gong C, Wang T-W, Huang HS and Parent JM (2007) Reelin regulates neuronal progenitor migration in intact and epileptic hippocampus. J Neurosci 27, 1803–1811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Guy J, Wagener RJ, Möck M and Staiger JF (2015) Persistence of Functional Sensory Maps in the Absence of Cortical Layers in the Somsatosensory Cortex of Reeler Mice. Cereb Cortex 25, 2517–2528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Hamad MIK, Jack A, Klatt O, Lorkowski M, Strasdeit T, Kott S, Sager C, Hollmann M and Wahle P (2014) Type I TARPs promote dendritic growth of early postnatal neocortical pyramidal cells in organotypic cultures. Development 141, 1737–1748. [DOI] [PubMed] [Google Scholar]
  33. Hamad MIK, Krause M and Wahle P (2015) Improving AM ester calcium dye loading efficiency. J Neurosci Methods 240, 48–60. [DOI] [PubMed] [Google Scholar]
  34. Hamad MIK, Ma-Högemeier Z-L, Riedel C, Conrads C, Veitinger T, Habijan T, Schulz J-N, Krause M, Wirth MJ, Hollmann M and Wahle P (2011) Cell class-specific regulation of neocortical dendrite and spine growth by AMPA receptor splice and editing variants. Development 138, 4301–4313. [DOI] [PubMed] [Google Scholar]
  35. Han HA, Cortez MA and Snead OC (2012), Jasper's Basic Mechanisms of the Epilepsies, Bethesda (MD). [Google Scholar]
  36. Hayashi S and McMahon AP (2002) Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre. Dev Biol 244, 305–318. [DOI] [PubMed] [Google Scholar]
  37. Hellwig S, Hack I, Kowalski J, Brunne B, Jarowyj J, Unger A, Bock HH, Junghans D and Frotscher M (2011) Role for Reelin in neurotransmitter release. J Neurosci 31, 2352–2360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Herz J, Goldstein JL, Strickland DK, Ho YK and Brown MS (1991) 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. J Biol Chem 266, 21232–21238. [PubMed] [Google Scholar]
  39. Hiesberger T, Trommsdorff M, Howell BW, Goffinet A, Mumby MC, Cooper JA and Herz J (1999) Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24, 481–489. [DOI] [PubMed] [Google Scholar]
  40. Hong SE, Shugart YY, Huang DT, Shahwan SA, Grant PE, Hourihane JO, Martin ND and Walsh CA (2000) Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nat Genet 26, 93–96. [DOI] [PubMed] [Google Scholar]
  41. Howell BW, Herrick TM, Hildebrand JD, Zhang Y and Cooper JA (2000) Dab1 tyrosine phosphorylation sites relay positional signals during mouse brain development. Curr Biol 10, 877–885. [DOI] [PubMed] [Google Scholar]
  42. Huang Y-WA, Zhou B, Wernig M and Südhof TC (2017) ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Aβ Secretion. Cell 168, 427–441.e21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Karbon EW and Enna SJ (1985) Characterization of the relationship between gamma-aminobutyric acid B agonists and transmitter-coupled cyclic nucleotide-generating systems in rat brain. Mol Pharmacol 27, 53–59. [PubMed] [Google Scholar]
  44. Karube F, Kubota Y and Kawaguchi Y (2004) Axon branching and synaptic bouton phenotypes in GABAergic nonpyramidal cell subtypes. J Neurosci 24, 2853–2865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Kawaguchi Y, Karube F and Kubota Y (2006) Dendritic branch typing and spine expression patterns in cortical nonpyramidal cells. Cereb Cortex 16, 696–711. [DOI] [PubMed] [Google Scholar]
  46. Kuramoto N, Wilkins ME, Fairfax BP, Revilla-Sanchez R, Terunuma M, Tamaki K, Iemata M, Warren N, Couve A, Calver A, Horvath Z, Freeman K, Carling D, Huang L, Gonzales C, Cooper E, Smart TG, Pangalos MN and Moss SJ (2007) Phospho-dependent functional modulation of GABA(B) receptors by the metabolic sensor AMP-dependent protein kinase. Neuron 53, 233–247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Lambert de Rouvroit C and Goffinet AM (1998) The reeler mouse as a model of brain development. Adv Anat Embryol Cell Biol 150, 1–106. [PubMed] [Google Scholar]
  48. Lane-Donovan C, Philips GT, Wasser CR, Durakoglugil MS, Masiulis I, Upadhaya A, Pohlkamp T, Coskun C, Kotti T, Steller L, Hammer RE, Frotscher M, Bock HH and Herz J (2015) Reelin protects against amyloid β toxicity in vivo. Sci Signal 8, ra67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. López-Bendito G, Shigemoto R, Kulik A, Paulsen O, Fairén A and Luján R (2002) Expression and distribution of metabotropic GABA receptor subtypes GABABR1 and GABABR2 during rat neocortical development. Eur J Neurosci 15, 1766–1778. [DOI] [PubMed] [Google Scholar]
  50. Ma YC, Huang J, Ali S, Lowry W and Huang XY (2000) Src tyrosine kinase is a novel direct effector of G proteins. Cell 102, 635–646. [DOI] [PubMed] [Google Scholar]
  51. Maier PJ, Marin I, Grampp T, Sommer A and Benke D (2010) Sustained glutamate receptor activation down-regulates GABAB receptors by shifting the balance from recycling to lysosomal degradation. J Biol Chem 285, 35606–35614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Miyata T, Nakajima K, Mikoshiba K and Ogawa M (1997) Regulation of Purkinje cell alignment by reelin as revealed with CR-50 antibody. J Neurosci 17, 3599–3609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Mott DD and Lewis DV (1991) Facilitation of the induction of long-term potentiation by GABAB receptors. Science 252, 1718–1720. [DOI] [PubMed] [Google Scholar]
  54. Nieto M, Monuki ES, Tang H, Imitola J, Haubst N, Khoury SJ, Cunningham J, Gotz M and Walsh CA (2004) Expression of Cux-1 and Cux-2 in the subventricular zone and upper layers II-IV of the cerebral cortex. J Comp Neurol 479, 168–180. [DOI] [PubMed] [Google Scholar]
  55. Nishikawa M and Kuriyama K (1989) Functional coupling of cerebral ?-aminobutyric acid (GABA)(B) receptor with adenylate cyclase system. Neurochem Int 14, 85–90. [DOI] [PubMed] [Google Scholar]
  56. Owens DF and Kriegstein AR (2002) Is there more to GABA than synaptic inhibition? Nat Rev Neurosci 3, 715–727. [DOI] [PubMed] [Google Scholar]
  57. Padgett CL, Lalive AL, Tan KR, Terunuma M, Munoz MB, Pangalos MN, Martínez-Hernández J, Watanabe M, Moss SJ, Luján R, Lüscher C and Slesinger PA (2012) Methamphetamine-evoked depression of GABA(B) receptor signaling in GABA neurons of the VTA. Neuron 73, 978–989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Palop JJ and Mucke L (2016) Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat Rev Neurosci 17, 777–792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Pinard A, Seddik R and Bettler B (2010) GABAB receptors. Adv Pharmacol 58, 231–255. [DOI] [PubMed] [Google Scholar]
  60. Pohlkamp T, Dávid C, Cauli B, Gallopin T, Bouché E, Karagiannis A, May P, Herz J, Frotscher M, Staiger JF and Bock HH (2014) Characterization and distribution of Reelin-positive interneuron subtypes in the rat barrel cortex. Cereb Cortex 24, 3046–3058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Sakaba T and Neher E (2003) Direct modulation of synaptic vesicle priming by GABA(B) receptor activation at a glutamatergic synapse. Nature 424, 775–778. [DOI] [PubMed] [Google Scholar]
  62. Terunuma M, Pangalos MN and Moss SJ (2010) Functional modulation of GABAB receptors by protein kinases and receptor trafficking. Adv Pharmacol 58, 113–122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Terunuma M, Vargas KJ, Wilkins ME, Ramírez OA, Jaureguiberry-Bravo M, Pangalos MN, Smart TG, Moss SJ and Couve A (2010) Prolonged activation of NMDA receptors promotes dephosphorylation and alters postendocytic sorting of GABAB receptors. PNAS 107, 13918–13923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Trommsdorff M, Gotthardt M, Hiesberger T, Shelton J, Stockinger W, Nimpf J, Hammer RE, Richardson JA and Herz J (1999) Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97, 689–701. [DOI] [PubMed] [Google Scholar]
  65. Wagener RJ, Dávid C, Zhao S, Haas CA and Staiger JF (2010) The somatosensory cortex of reeler mutant mice shows absent layering but intact formation and behavioral activation of columnar somatotopic maps. J Neurosci 30, 15700–15709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Weir K, Blanquie O, Kilb W, Luhmann HJ and Sinning A (2014) Comparison of spike parameters from optically identified GABAergic and glutamatergic neurons in sparse cortical cultures. Front Cell Neurosci 8, 460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Welt C and Steindler DA (1977) Somatosensory cortical barrels and thalamic barreloids in reeler mutant mice. Neuroscience 2, 755–766. [DOI] [PubMed] [Google Scholar]
  68. Willnow TE, Rohlmann A, Horton J, Otani H, Braun JR, Hammer RE and Herz J (1996) RAP, a specialized chaperone, prevents ligand-induced ER retention and degradation of LDL receptor-related endocytic receptors. EMBO J 15, 2632–2639. [PMC free article] [PubMed] [Google Scholar]
  69. Xiao M-F, Xu D, Craig MT, Pelkey KA, Chien C-C, Shi Y, Zhang J, Resnick S, Pletnikova O, Salmon D, Brewer J, Edland S, Wegiel J, Tycko B, Savonenko A, Reeves RH, Troncoso JC, McBain CJ, Galasko D and Worley PF (2017) NPTX2 and cognitive dysfunction in Alzheimer's Disease. eLife 6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Xu J and Wojcik WJ (1986) Gamma aminobutyric acid B receptor-mediated inhibition of adenylate cyclase in cultured cerebellar granule cells. J Pharmacol Exp Ther 239, 568–573. [PubMed] [Google Scholar]
  71. Yuste R, MacLean J, Vogelstein J and Paninski L (2011) Imaging action potentials with calcium indicators. Cold Spring Harb Protoc 2011, 985–989. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

figures S1-S8

Fig. S1. Expression of neocortical markers in wt and RelncKO mice.

Fig. S2. Effect of chronic 4-OHT treatment on Ca2+ spontaneous activity in OTCs

Fig. S3. Immunolabelling of GCaMP6s transfected cells with GAD-65.

Fig. S4. Effect of glutamatergic transmission blockade on spontaneous activity in RelncKO mice.

Fig. S5. Cre recombinase and Reelin immunostaining from DIV14 4-OHT treated OTCs.

Fig. S6. PP2 reduces surface GABABR1 and GABABR2 expression in wt OTCs.

Fig. S7. Secreted Reelin rescues surface expression of GABABR2 in RelncKO OTCs.

Fig. S8. Effect of acute PTX application on Ca2+ signaling in RelncKO OTCs.

movie S1

Movie S1. Baclofen inhibits Ca2+ spike activity in wt OTCs.

Download video file (12.1MB, avi)
movie S2

Movie S2. Baclofen did not affect Ca2+ spike activity in RelncKO OTCs.

Download video file (11.7MB, avi)

RESOURCES